- The prime time for management of hepatocellular carcinoma in Hong Kong
-
Chan LL, Chan SL
- KMID: 2541413
- Clin Mol Hepatol.
- 2023 Apr;29(2):345-348.
- doi: 10.3350/cmh.2023.0094
-
- CITED
-
- Close
- SHARE
-
- Close
- The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
-
Chan LL, Chan SL
- KMID: 2546377
- Clin Mol Hepatol.
- 2023 Oct;29(4):909-923.
- doi: 10.3350/cmh.2023.0114
Emergence of multi-targeted kinase inhibitors (MTIs) and immune checkpoint inhibitors (ICI) have changed the landscape of management in hepatocellular carcinoma (HCC). Combination therapy involving ICI has superseded sorafenib as the... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
-
Lee MMP, Chan LL, Chan SL
- KMID: 2546408
- J Liver Cancer.
- 2023 Sep;23(2):262-271.
- doi: 10.17998/jlc.2023.07.17
Hepatocellular carcinoma (HCC) frequently presents as advanced stage with poor prognosis and high mortality. Systemic treatment is the treatment of choice for advanced disease. In 2007, the first multi-kinase inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?
-
Chong TT, Yap HY, Tan CS, Lee QS, Chan SL, Yan Wee IJ, Tang TY
- KMID: 2502280
- Vasc Spec Int.
- 2020 Mar;36(1):21-27.
- doi: 10.5758/vsi.2020.36.1.21
Purpose: Central venous stenosis is a recurring problem affecting dialysis access patency. Increasing evidence suggests that the use of drug-coated balloons (DCBs) improves target lesion primary patency (TLPP) in dialysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
-
Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, Izumi N, Huyen NN, Chow PKH, Mohamed R, Chan SL, Tanwandee T, Lee TY, Hai TTN, Yang T, Lee WC, Chan HLY
- KMID: 2541406
- Clin Mol Hepatol.
- 2023 Apr;29(2):277-292.
- doi: 10.3350/cmh.2022.0212
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP has its challenges, including accuracy dependent... -
- CITED
-
- Close
- SHARE
-
- Close
